Keros Therapeutics, Inc.

Historical 13F Holders

Symbol
KROS
CUSIP
492327101
All holders as of
Q2 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings
Period Filings Shares, Excl. Options Value, Excl. Options
2025 Q2 149 37.2 M $497 M
2025 Q1 174 36.7 M $429 M
2024 Q4 177 36.8 M $582 M
2024 Q3 176 35.0 M $2.03 B
2024 Q2 161 32.2 M $1.47 B
2024 Q1 158 32.0 M $2.12 B
2023 Q4 131 27.3 M $1.08 B
2023 Q3 111 22.9 M $730 M
2023 Q2 129 22.4 M $901 M
2023 Q1 136 22.0 M $937 M
2022 Q4 133 20.8 M $998 M
2022 Q3 118 18.2 M $683 M
2022 Q2 106 17.4 M $480 M
2022 Q1 111 16.4 M $893 M
2021 Q4 105 16.2 M $945 M
2021 Q3 90 13.8 M $545 M
2021 Q2 81 14.1 M $600 M
2021 Q1 84 14.4 M $887 M
2020 Q4 83 16.0 M $1.13 B
2020 Q3 50 11.8 M $455 M
2020 Q2 52 10.9 M $410 M